Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call Transcript

SA Transcripts 161.6K Followers Follow Trevi Therapeutics, Inc. ( TRVI ) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDT Company Participants Jennifer Good - Co-Founder, CEO, President, & Director David Hastings - Chief Financial Officer & Principal Financial Officer James Cassella - Chief Development Officer Farrell Simon - Chief Commercial Officer Conference Call Participants Roanna Clarissa Ruiz - Leerink Partners LLC, Research Division Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division Judah Frommer - Morgan Stanley, Research Division Ryan Deschner - Raymond James & Associates, Inc., Research Division John Gionco - Needham & Company, LLC, Research Division William Wood - B. Riley Securities, Inc., Research Division Conor MacKay - BMO Capital Markets Equity Research Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of '95. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent annual report Form 10-K, which the company filed with the SEC on March 17, 2026, as updated by our subsequent filings with the SEC. In addition, any forward-looking statements represents the company's views only as of today and should not be relied upon as representing the company's views as of any subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so, even if its views change. I would now like to turn the conference call over to Jennifer Good, Trevi's President and CEO. Please go ahead.